• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

ISN +Respiri Company Presentation - May 2016-ISN.AX 19/05/16
ISN +Letter to Ineligible Shareholders - Rights Issue-ISN.AX 19/05/16
ISN +Letter to Eligible Shareholders - Rights Issue-ISN.AX 19/05/16
ISN +Offer Booklet for Renounceable Pro-Rata Rights Issue-ISN.AX PRICE SENSITIVE19/05/16
ISN +Letter to Optionholders - Rights Issue-ISN.AX 19/05/16
ISN +Section 708AA Notice-ISN.AX 19/05/16
ISN +Section 708A Notice-ISN.AX 19/05/16
ISN +Reinstatement to Official Quotation-ISN.AX PRICE SENSITIVE19/05/16
ISN +Respiri Announces $4.3M Fully Underwritten Rights Issue-ISN.AX PRICE SENSITIVE19/05/16
ISN +Suspension from Official Quotation-ISN.AX PRICE SENSITIVE18/05/16
ISN +Appendix 4C - quarterly-ISN.AX PRICE SENSITIVE28/04/16
ISN iSonea Appoints Deloitte Touche Tohmatsu as Company Auditor30/11/15
ISN Results of iSonea 2015 Annual General Meeting26/11/15
ISN 2015 Annual General Meeting - Chairman's Address26/11/15
ISN Chicago University IRB Approves AirSonea Research Study25/11/15
ISN iSonea to Exhibit at China Hi-Tech Fair in Shenzhen China05/11/15
ISN Notice of Annual General Meeting & Explanatory Memorandum27/10/15
ISN Appendix 4C - quarterlyPRICE SENSITIVE26/10/15
ISN Appendix 4G08/09/15
ISN Annual Report to Shareholders08/09/15
ISN Appendix 4E - Preliminary Final Report - June 2015PRICE SENSITIVE31/08/15
ISN Change of Registered Office20/08/15
ISN Clinical Trial Update - Second Generation AirSoneaPRICE SENSITIVE12/08/15
ISN Major Advance for Second Generation AirSonea Wheeze MonitorPRICE SENSITIVE06/08/15
ISN Appendix 4C - Fourth Quarter Cash Report - FY2015PRICE SENSITIVE23/07/15
ISN iSonea Presents at Canary Biotech & Healthcare Investor Show08/07/15
ISN iSonea to Commence Commercial Partnership DiscussionsPRICE SENSITIVE03/06/15
ISN ISN Update - Nth American Mkt & Clinical Trials (May 2015)PRICE SENSITIVE28/05/15
ISN Appendix 4C - Third Quarter Cash Report - FY2015PRICE SENSITIVE28/04/15
ISN Appendix 3Y - Change of Director's Interest Notice (DA)26/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (RBH)20/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (JR)19/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (DA)06/03/15
MPL +S&P DJ Indices Announces March Quarterly ReviewPRICE SENSITIVE06/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (JR)05/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (TO)04/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (LL)04/03/15
ISN iSonea Company Update - Feb 201527/02/15
ISN Appendix 4D and Interim Financial Report - Dec 2014PRICE SENSITIVE27/02/15
ISN Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
ISN Preperation for Clinical Trial and Product Relaunch23/01/15
ISN Appendix 3Y - Change in Directors Interest Notices (x4)12/12/14
ISN Appendix 3B and Cleansing Notice12/12/14
ISN Results of Annual General Meeting28/11/14
ISN Appendix 3Z - Final Director's Interest Notice (BM)28/11/14
ISN Appendix 3X - Initial Director's Interest Notice (RBH)28/11/14
ISN iSonea Appoints Mr Ross Blair-Holt as a Director28/11/14
ISN Chairman's 2014 AGM Address to Shareholders28/11/14
ISN Appendix 4C - First Quarter Cash Report - FY2015PRICE SENSITIVE31/10/14
ISN Notice of Annual General Meeting29/10/14
ISN Annual Report to shareholders01/10/14
ISN Final Director's Interest Notice - ST25/09/14
ISN Accelerating Commercialisation After Strengthening Business24/09/14
ISN Response to ASX Price QueryPRICE SENSITIVE09/09/14
ISN Appendix 4E - Preliminary Final Report - June 2014PRICE SENSITIVE29/08/14
ISN iSonea Strengthens Leadership in Respiratory mHealth TechPRICE SENSITIVE22/08/14
ISN Appendix 4C - Fourth Quarter Cash Report and Investor UpdatePRICE SENSITIVE30/07/14
ISN Appendix 3B - Exercise of ISNOB Listed Options04/07/14
ISN Appendix 3Y - Change of Director's Interest Notice (ST)04/07/14
ISN Form 604 - Change in Substantial Shareholder (B.Mathieson)01/07/14
ISN Appendix 3B - Exercise of ISNOB Listed Options27/06/14
ISN FDA Approval for SonoSentry is Close23/06/14
ISN Appendix 3B - Exercise of ISNOB Listed Options20/06/14
ISN Appendix 3X - Inital Director's Interest Notice (DA)19/06/14
ISN iSonea Appoints New Director - David Ashmore19/06/14
ISN Appendix 3B - Exercise of ISNOB Listed Options13/06/14
ISNAppendix 3B - Exercise of ISNOB Listed Options06/06/14
ISNAppendix 3B - Exercise of ISNOB Listed Options30/05/14
ISNLetter to Optionholders - Expiry of ISNOB Listed Options27/05/14
ISNResponse to ASX Price QueryPRICE SENSITIVE26/05/14
ISNAppendix 3B05/05/14
ISNAppendix 4C - Third Quarter Cash Report and Investor UpdatePRICE SENSITIVE16/04/14
ISNAppendix 3B - Exercise of ISNOB Options21/03/14
ISNNew England Journal of Medicine - Portable Acoustic Devices07/03/14
AAI +S&P DJ Indices Announces March Quarterly Rebalance07/03/14
ISNAppendix 3B - Exercise of ISNOB Listed Options28/02/14
ISNAppendix 4D and Interim Financial Report - Dec 2013PRICE SENSITIVE28/02/14
ISNAppendix 3B - Exercise of ISNOB Options17/02/14
ISNAppendix 3Z - Final Director Interest Notice x4(RH,JK,DD,RM)05/02/14
ISNAppendix 3X-Initial Director Interest Notice x4(LL,BM,JR,ST)05/02/14
ISNiSonea Takes Next Steps to Commercialise Asthma Mgmt TechPRICE SENSITIVE04/02/14
ISNTrading HaltPRICE SENSITIVE03/02/14
ISNRequest for trading halt03/02/14
ISNAppendix 4C - Quarterly Cashflow Report (Oct - Dec 2013)PRICE SENSITIVE03/02/14
ISNiSonea Investor Update Presentation - January 201423/01/14
ISNAsthma Technology Awarded at International CES Conference22/01/14
ISNAppendix 3B17/01/14
ISNISN to Present Next Gen Asthma Product at Global Tech Conf07/01/14
ISNAppendix 3X - Initial Director's Interest Notice (TO)06/01/14
ISNAppendix 3Z - Final Director's Interest Notice (SW)06/01/14
ISNiSonea Board and Management ChangesPRICE SENSITIVE06/01/14
ISNAppendix 3B - Exercise of ISNOB Options27/12/13
ISNiSonea To Drive Aggressive AirSonea Sales Plan in AustraliaPRICE SENSITIVE23/12/13
ISNResponse to ASX Price QueryPRICE SENSITIVE18/12/13
ISNAppendix 3Y's - Change of Director's Interest Notices (x5)05/12/13
ISNAppendix 3B29/11/13
ISNAppendix 3B - Exercise of ISNOB Options14/11/13
ISNiSonea Technology Featured on National Television Program14/11/13
ISNCEO to Step DownPRICE SENSITIVE13/11/13
ISNResults of 2013 Annual General Meeting31/10/13
ISN +Respiri Company Presentation - May 2016-ISN.AX
19/05/16
ISN +Letter to Ineligible Shareholders - Rights Issue-ISN.AX
19/05/16
ISN +Letter to Eligible Shareholders - Rights Issue-ISN.AX
19/05/16
ISN +Offer Booklet for Renounceable Pro-Rata Rights Issue-ISN.AX
19/05/16PRICE SENSITIVE
ISN +Letter to Optionholders - Rights Issue-ISN.AX
19/05/16
ISN +Section 708AA Notice-ISN.AX
19/05/16
ISN +Section 708A Notice-ISN.AX
19/05/16
ISN +Reinstatement to Official Quotation-ISN.AX
19/05/16PRICE SENSITIVE
ISN +Respiri Announces $4.3M Fully Underwritten Rights Issue-ISN.AX
19/05/16PRICE SENSITIVE
ISN +Suspension from Official Quotation-ISN.AX
18/05/16PRICE SENSITIVE
ISN +Appendix 4C - quarterly-ISN.AX
28/04/16PRICE SENSITIVE
ISN iSonea Appoints Deloitte Touche Tohmatsu as Company Auditor
30/11/15
ISN Results of iSonea 2015 Annual General Meeting
26/11/15
ISN 2015 Annual General Meeting - Chairman's Address
26/11/15
ISN Chicago University IRB Approves AirSonea Research Study
25/11/15
ISN iSonea to Exhibit at China Hi-Tech Fair in Shenzhen China
05/11/15
ISN Notice of Annual General Meeting & Explanatory Memorandum
27/10/15
ISN Appendix 4C - quarterly
26/10/15PRICE SENSITIVE
ISN Appendix 4G
08/09/15
ISN Annual Report to Shareholders
08/09/15
ISN Appendix 4E - Preliminary Final Report - June 2015
31/08/15PRICE SENSITIVE
ISN Change of Registered Office
20/08/15
ISN Clinical Trial Update - Second Generation AirSonea
12/08/15PRICE SENSITIVE
ISN Major Advance for Second Generation AirSonea Wheeze Monitor
06/08/15PRICE SENSITIVE
ISN Appendix 4C - Fourth Quarter Cash Report - FY2015
23/07/15PRICE SENSITIVE
ISN iSonea Presents at Canary Biotech & Healthcare Investor Show
08/07/15
ISN iSonea to Commence Commercial Partnership Discussions
03/06/15PRICE SENSITIVE
ISN ISN Update - Nth American Mkt & Clinical Trials (May 2015)
28/05/15PRICE SENSITIVE
ISN Appendix 4C - Third Quarter Cash Report - FY2015
28/04/15PRICE SENSITIVE
ISN Appendix 3Y - Change of Director's Interest Notice (DA)
26/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (RBH)
20/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (JR)
19/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (DA)
06/03/15
MPL +S&P DJ Indices Announces March Quarterly Review
06/03/15PRICE SENSITIVE
ISN Appendix 3Y - Change in Directors Interest Notice (JR)
05/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (TO)
04/03/15
ISN Appendix 3Y - Change in Directors Interest Notice (LL)
04/03/15
ISN iSonea Company Update - Feb 2015
27/02/15
ISN Appendix 4D and Interim Financial Report - Dec 2014
27/02/15PRICE SENSITIVE
ISN Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
ISN Preperation for Clinical Trial and Product Relaunch
23/01/15
ISN Appendix 3Y - Change in Directors Interest Notices (x4)
12/12/14
ISN Appendix 3B and Cleansing Notice
12/12/14
ISN Results of Annual General Meeting
28/11/14
ISN Appendix 3Z - Final Director's Interest Notice (BM)
28/11/14
ISN Appendix 3X - Initial Director's Interest Notice (RBH)
28/11/14
ISN iSonea Appoints Mr Ross Blair-Holt as a Director
28/11/14
ISN Chairman's 2014 AGM Address to Shareholders
28/11/14
ISN Appendix 4C - First Quarter Cash Report - FY2015
31/10/14PRICE SENSITIVE
ISN Notice of Annual General Meeting
29/10/14
ISN Annual Report to shareholders
01/10/14
ISN Final Director's Interest Notice - ST
25/09/14
ISN Accelerating Commercialisation After Strengthening Business
24/09/14
ISN Response to ASX Price Query
09/09/14PRICE SENSITIVE
ISN Appendix 4E - Preliminary Final Report - June 2014
29/08/14PRICE SENSITIVE
ISN iSonea Strengthens Leadership in Respiratory mHealth Tech
22/08/14PRICE SENSITIVE
ISN Appendix 4C - Fourth Quarter Cash Report and Investor Update
30/07/14PRICE SENSITIVE
ISN Appendix 3B - Exercise of ISNOB Listed Options
04/07/14
ISN Appendix 3Y - Change of Director's Interest Notice (ST)
04/07/14
ISN Form 604 - Change in Substantial Shareholder (B.Mathieson)
01/07/14
ISN Appendix 3B - Exercise of ISNOB Listed Options
27/06/14
ISN FDA Approval for SonoSentry is Close
23/06/14
ISN Appendix 3B - Exercise of ISNOB Listed Options
20/06/14
ISN Appendix 3X - Inital Director's Interest Notice (DA)
19/06/14
ISN iSonea Appoints New Director - David Ashmore
19/06/14
ISN Appendix 3B - Exercise of ISNOB Listed Options
13/06/14
ISNAppendix 3B - Exercise of ISNOB Listed Options
06/06/14
ISNAppendix 3B - Exercise of ISNOB Listed Options
30/05/14
ISNLetter to Optionholders - Expiry of ISNOB Listed Options
27/05/14
ISNResponse to ASX Price Query
26/05/14PRICE SENSITIVE
ISNAppendix 3B
05/05/14
ISNAppendix 4C - Third Quarter Cash Report and Investor Update
16/04/14PRICE SENSITIVE
ISNAppendix 3B - Exercise of ISNOB Options
21/03/14
ISNNew England Journal of Medicine - Portable Acoustic Devices
07/03/14
AAI +S&P DJ Indices Announces March Quarterly Rebalance
07/03/14
ISNAppendix 3B - Exercise of ISNOB Listed Options
28/02/14
ISNAppendix 4D and Interim Financial Report - Dec 2013
28/02/14PRICE SENSITIVE
ISNAppendix 3B - Exercise of ISNOB Options
17/02/14
ISNAppendix 3Z - Final Director Interest Notice x4(RH,JK,DD,RM)
05/02/14
ISNAppendix 3X-Initial Director Interest Notice x4(LL,BM,JR,ST)
05/02/14
ISNiSonea Takes Next Steps to Commercialise Asthma Mgmt Tech
04/02/14PRICE SENSITIVE
ISNTrading Halt
03/02/14PRICE SENSITIVE
ISNRequest for trading halt
03/02/14
ISNAppendix 4C - Quarterly Cashflow Report (Oct - Dec 2013)
03/02/14PRICE SENSITIVE
ISNiSonea Investor Update Presentation - January 2014
23/01/14
ISNAsthma Technology Awarded at International CES Conference
22/01/14
ISNAppendix 3B
17/01/14
ISNISN to Present Next Gen Asthma Product at Global Tech Conf
07/01/14
ISNAppendix 3X - Initial Director's Interest Notice (TO)
06/01/14
ISNAppendix 3Z - Final Director's Interest Notice (SW)
06/01/14
ISNiSonea Board and Management Changes
06/01/14PRICE SENSITIVE
ISNAppendix 3B - Exercise of ISNOB Options
27/12/13
ISNiSonea To Drive Aggressive AirSonea Sales Plan in Australia
23/12/13PRICE SENSITIVE
ISNResponse to ASX Price Query
18/12/13PRICE SENSITIVE
ISNAppendix 3Y's - Change of Director's Interest Notices (x5)
05/12/13
ISNAppendix 3B
29/11/13
ISNAppendix 3B - Exercise of ISNOB Options
14/11/13
ISNiSonea Technology Featured on National Television Program
14/11/13
ISNCEO to Step Down
13/11/13PRICE SENSITIVE
ISNResults of 2013 Annual General Meeting
31/10/13
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.
Fatal error: Uncaught ErrorException: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: ) in /data/vhosts/test/hotcopper-git/upload/darkhorse/vendor/zendframework/zend-session/src/SessionManager.php:236 Stack trace: #0 [internal function]: Application\Service\AppManager::handlePhpError(2, 'session_write_c...', '/data/vhosts/te...', 236, Array) #1 /data/vhosts/test/hotcopper-git/upload/darkhorse/vendor/zendframework/zend-session/src/SessionManager.php(236): session_write_close() #2 [internal function]: Zend\Session\SessionManager->writeClose() #3 {main} thrown in /data/vhosts/test/hotcopper-git/upload/darkhorse/vendor/zendframework/zend-session/src/SessionManager.php on line 236